Industry News
Pharmaceutical Industry News
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal
President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.
In a merger between two…
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi.
Cancer rates are rising in young…
Cancer rates are rising in young adults. Is current care keeping up? Discover how AI and tech can bridge the gap.
In the latest instance of pharma…
In the latest instance of pharma tariff whiplash, the import duties promised by the president last week are reportedly on hold.
On The Top Line, IQVIA’s Marie…
On The Top Line, IQVIA’s Marie Flanagan explains why governance must be built into AI design from the start.
With a government shutdown now in…
With a government shutdown now in effect, the U.S. FDA—already shaken up by head count reductions earlier this year—has sought to keep many of its functions running for the foreseeable future.
AbbVie has kicked off work on a…
AbbVie has kicked off work on a $70 million expansion of its bioresearch center in Worcester, Massachusetts, where the company conducts both manufacturing and R&D for biologic medicines. The project falls under the banner of
A Sanofi spokesperson confirmed to…
A Sanofi spokesperson confirmed to Fierce that it is the company at the center of the investigation.
Bayer’s consumer health unit has…
Bayer’s consumer health unit has named Interpublic Group as its creative, production and media partner, integrating the work at a single agency to boost its buying power and leverage generative AI.
Trump Announces Pfizer Deal to Lower Some Drug Prices and Unveils TrumpRx Website
The administration also announced it will create a website, TrumpRx, that will help consumers buy drugs directly from manufacturers.
Novartis has scored the FDA’s…
Novartis has scored the FDA’s approval for a second BTK inhibitor that’s for a non-cancer indication, teeing off potential competition with Sanofi down the line.
The Sept. 29 settlement was the…
The Sept. 29 settlement was the result of an investigation by New York’s Office of the Attorney General into a county sheriff’s office's purchase of Opvee.
South Korea-based Boryung…
South Korea-based Boryung Corporation is boosting its global oncology foothold with a deal to take on Sanofi’s time-honored chemotherapy Taxotere (docetaxel) in nearly 20 markets.
The FDA is not feeling the love in…
The FDA is not feeling the love in a commercial for Novartis’ paroxysmal nocturnal hemoglobinuria treatment Fabhalta.
A now-deleted LinkedIn post from a…
A now-deleted LinkedIn post from a top FDA official has raised the hackles of Aurinia Pharmaceuticals as industry watchers puzzle over the official's decision to target the approvability of surrogate endpoints—and single out Aurinia’s lupus
Laboratorios Farmacéuticos Rovi,…
Laboratorios Farmacéuticos Rovi, which goes by Rovi, inked a $250 million deal with Bristol Myers Squibb that gives the Spanish CDMO a vaccine and biosimilar production facility in Phoenix as part of an overall manufacturing
True Crime to Stream: Medical Mayhem
Across television, film and podcast, these four stories use personal tragedies as a way to illuminate bigger institutional failures in health care.
Bill Nye is back in the lab….
Bill Nye is back in the lab. Backed by Biogen, the television presenter is starring in a four-part web series that brings the quirky humor of “Bill Nye the Science Guy” to the science of
Two clinical trials of Merck’s…
Two clinical trials of Merck’s pulmonary arterial hypertension drug Winrevair were so conclusive that the studies were halted because the efficacy of the treatment was assured. Now, Merck has reported results from the phase 3
Lance Hill and Jason Smith…
Lance Hill and Jason Smith highlight AI, data and evolving strategies for commercial and medical affairs teams